Scheduling synthetic cathinone substances under the Controlled Substances Act.

Area of Science:

• Forensic Chemistry
• Neuroscience
• Public Health Policy

Background:

• Synthetic cathinones are amphetamine analogues with stimulant and rewarding effects.
• Widespread abuse in the USA has raised public safety concerns.
• The Controlled Substances Act (CSA) allows scheduling of drugs with high abuse potential and no medical use.

Purpose of the Study:

• To detail the process of scheduling synthetic cathinones under the CSA.
• To highlight the scientific and medical analysis involved in drug scheduling.
• To emphasize governmental transparency in drug control decisions.

Main Methods:

• Review of synthetic cathinone scheduling under the CSA from 1973-2018.
• Emphasis on 10 cathinones scheduled in 2017.
• Summary of the Eight-Factor Analysis (8FA) conducted by HHS.

Main Results:

• Numerous synthetic cathinones were placed under CSA control.
• Ten specific cathinones underwent detailed HHS scientific and medical review (8FA).
• These 10 cathinones were permanently placed into Schedule I by the DEA.

Conclusions:

• The CSA scheduling process for cathinones involves rigorous scientific and medical evaluation.
• Understanding this process is crucial for governmental transparency.
• The scheduling ensures control of substances with high abuse potential and no accepted medical use.